Une infirmière prépare une injection pour un essai clinique d'un candidat-vaccin contre la COVID-19 développé par les National Institutes of Health et Moderna, le 27 juillet 2020 à Binghamton, N.Y. AP Photo/Hans Pennink

Covid‑19 : six choses que vous devez savoir sur les résultats des vaccins

Les nouvelles sur les essais cliniques de vaccins contre la Covid-19 font les manchettes. Mais que signifient vraiment ces résultats ? Voici six questions à se poser pour bien comprendre.
A nurse prepares a shot for a clinical trial of a COVID-19 vaccine candidate developed by the National Institutes of Health and Moderna Inc., on July 27, 2020 in Binghamton, N.Y. (AP Photo/Hans Pennink, File)

COVID‑19 vaccine FAQ: 6 things to look for in clinical trial results

With COVID-19 vaccine announcements making headlines, non-scientists need to know what clinical trial results mean. Here are some key points to look for in vaccine trial reports.
Doctors reported the first cases of MIS-C in April. Learning more about how SARS-CoV-2 affects children is essential to the safe reopening of communities. (Pexels/August de Richelieu)

Rare multisystem inflammatory syndrome in children linked to coronavirus

A rare new disease syndrome appears to be caused by an overactive immune response in children, often hitting weeks after exposure to the SARS-CoV-2 virus.

Contact Alan for

  • General
  • Media request
  • Speaking request
  • Consulting / Advising
  • Research collaboration